ARCHIVES

Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology

This article is from The Cancer Letter archive.

Vol. 28 No. 14 | April 5, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Records Clear Flood Of Intervention For Man Accused Of Illegal Payoffs

February 3, 1978

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

Consensus Conference On Localized Prostate Cancer June 15-17

November 21, 1986

Senate Markup Would Give NCI $985 Million, Offers Prospect That Reductions In Grants Will Be Restored

December 10, 1982

NCCS Networker Volume 8 Issue 2, Summer 1994

June 13, 1994

ACS Forms Foundation To Handle Large Gifts

September 4, 1992